SI1493441T1 - Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano - Google Patents

Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano

Info

Publication number
SI1493441T1
SI1493441T1 SI200332073T SI200332073T SI1493441T1 SI 1493441 T1 SI1493441 T1 SI 1493441T1 SI 200332073 T SI200332073 T SI 200332073T SI 200332073 T SI200332073 T SI 200332073T SI 1493441 T1 SI1493441 T1 SI 1493441T1
Authority
SI
Slovenia
Prior art keywords
group
therapeutic agent
competence
stomach
disorder
Prior art date
Application number
SI200332073T
Other languages
English (en)
Slovenian (sl)
Inventor
Yugo Matsunaga
Shigeru Ueki
Raita Higashino
Masanao Kawachi
Hiroki Kato
Shiro Kobayashi
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28786350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1493441(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Publication of SI1493441T1 publication Critical patent/SI1493441T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200332073T 2002-04-08 2003-04-08 Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano SI1493441T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002104894 2002-04-08
PCT/JP2003/004445 WO2003084537A1 (en) 2002-04-08 2003-04-08 Therapeutic agent for food competence disorder in stomach
EP03745958A EP1493441B1 (en) 2002-04-08 2003-04-08 Therapeutic agent for food competence disorder in stomach

Publications (1)

Publication Number Publication Date
SI1493441T1 true SI1493441T1 (sl) 2011-12-30

Family

ID=28786350

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332073T SI1493441T1 (sl) 2002-04-08 2003-04-08 Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano

Country Status (14)

Country Link
US (4) US20050176788A1 (cg-RX-API-DMAC7.html)
EP (2) EP2301540A1 (cg-RX-API-DMAC7.html)
JP (2) JP5281226B2 (cg-RX-API-DMAC7.html)
KR (4) KR101423284B1 (cg-RX-API-DMAC7.html)
CN (2) CN1646123A (cg-RX-API-DMAC7.html)
AT (1) ATE522214T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003236326B2 (cg-RX-API-DMAC7.html)
CA (1) CA2481916C (cg-RX-API-DMAC7.html)
CY (1) CY1112057T1 (cg-RX-API-DMAC7.html)
DK (1) DK1493441T3 (cg-RX-API-DMAC7.html)
ES (1) ES2368732T3 (cg-RX-API-DMAC7.html)
PT (1) PT1493441E (cg-RX-API-DMAC7.html)
SI (1) SI1493441T1 (cg-RX-API-DMAC7.html)
WO (1) WO2003084537A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447612A (zh) * 2013-09-16 2015-03-25 天津市汉康医药生物技术有限公司 阿考替胺水合物晶型及其制备方法和用途
CN103980226A (zh) * 2014-05-10 2014-08-13 杭州新博思生物医药有限公司 盐酸阿考替胺水合物晶型及其制备方法
CN105315225A (zh) * 2014-07-07 2016-02-10 中美华世通生物医药科技（武汉）有限公司 阿考替胺的酸加成盐及其制备方法
CN104045606B (zh) * 2014-07-11 2015-09-30 杭州新博思生物医药有限公司 一锅法制备阿考替胺盐酸盐的方法
CN109988121B (zh) * 2019-04-28 2023-01-03 梯尔希（南京）药物研发有限公司 一种阿考替胺衍生物的制备方法
MX2024000751A (es) 2021-07-14 2024-03-25 Blueprint Medicines Corp Compuestos heterociclicos como inhibidores de map4k1.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063442C (zh) * 1995-05-18 2001-03-21 泽里新药工业株式会社 氨基噻唑衍生物、含有它们的药物组合物及其用途
JPH10212271A (ja) * 1997-01-31 1998-08-11 Zeria Pharmaceut Co Ltd Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
PT994108E (pt) * 1997-06-24 2003-09-30 Zeria Pharm Co Ltd Processo de producao de derivados de 2-hidroxibenzamida
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
NZ511117A (en) * 1998-11-23 2002-11-26 Janssen Pharmaceutica Nv Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
JP2003501427A (ja) * 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アミノアルキル置換（ベンゾジオキサン、ベンゾフランもしくはベンゾピラン）誘導体
CA2391497C (en) * 1999-11-23 2008-12-30 Janssen Pharmaceutica N.V. Use of 5ht3 agonists for relaxing the fundus
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
JP4876367B2 (ja) * 2000-09-08 2012-02-15 ゼリア新薬工業株式会社 アミノチアゾール誘導体を有効成分とする大腸運動不全治療剤
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia

Also Published As

Publication number Publication date
KR20120037035A (ko) 2012-04-18
KR101423284B1 (ko) 2014-07-24
AU2003236326B2 (en) 2008-02-28
ES2368732T3 (es) 2011-11-21
JP5281226B2 (ja) 2013-09-04
PT1493441E (pt) 2011-09-28
EP1493441B1 (en) 2011-08-31
JP2011068692A (ja) 2011-04-07
CA2481916C (en) 2013-02-26
EP1493441A1 (en) 2005-01-05
DK1493441T3 (da) 2011-10-17
JPWO2003084537A1 (ja) 2005-08-11
US20090156652A1 (en) 2009-06-18
KR20130101162A (ko) 2013-09-12
KR20050002925A (ko) 2005-01-10
CY1112057T1 (el) 2015-11-04
EP1493441A4 (en) 2007-10-17
ATE522214T1 (de) 2011-09-15
US20200375954A1 (en) 2020-12-03
KR20110010837A (ko) 2011-02-07
JP5360075B2 (ja) 2013-12-04
WO2003084537A1 (en) 2003-10-16
US20150141475A1 (en) 2015-05-21
CA2481916A1 (en) 2003-10-16
EP2301540A1 (en) 2011-03-30
CN1646123A (zh) 2005-07-27
AU2003236326A1 (en) 2003-10-20
CN102125551B (zh) 2015-07-22
CN102125551A (zh) 2011-07-20
US20050176788A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
HU229581B1 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
MY136581A (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
NO20051209L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme
EP1609798A4 (en) CONDENSED HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, AND MEDICAL USE THEREOF
EP1698624A4 (en) phenylpropanoic acid derivatives
AU4396899A (en) Remedies for diabetes
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
EP1634874A4 (en) imidazolidine
AU2006325931A8 (en) Amine compound and use thereof for medical purposes
PT1493441E (pt) Agente terapêutico para a desordem de competência alimentar no estômago
MY122570A (en) Benzamide derivatives and drugs containing the same
PL1970372T3 (pl) Sole kwasu 9-oksoakrydyno-10-octowego z 1-alkiloamino-1-deoksypoliolami
TW200505892A (en) Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use
PL377462A1 (pl) Pochodna oligosacharydowa
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
EP1500656A4 (en) BIGUANIDE DERIVATIVE AND DIABETES TREATMENT AGENT CONTAINING
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
ZA200800999B (en) Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
MXPA06000651A (es) Uso de derivados de indazol para el tratamiento de dolor neuropatico.
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.
TH75657A (th) อนุพันธ์ของไพโรโลไพริไมดีน